Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.
The onset of the COVID-19 pandemic has introduced a variety of challenges to “business as usual.” The virus and the ensuing...
Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, COVID-19
Managing the COVID-19 pandemic has prompted countries and regions around the world to introduce a series of adaptions. For the...
Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, COVID-19
Ulcerative Colitis, or UC, is a chronic condition that is characterized by inflammation of the colon. Most people with UC will...
Tags: Autoimmune, CRO Services
COVID-19 has presented a variety of challenges. The way people live their lives and conduct their work has been disrupted....
Tags: Pharm-Olam Insights, COVID-19
Earned Value Management or EVM is changing the way that companies do business. You may have heard that statement before, about...
Tags: Pharm-Olam Insights
Risk assessments are often an afterthought. A company is required to be audited, and the auditor finds gaps or holes in its...
Tags: Pharm-Olam Insights, CRO Services
Medicine is continually advancing. New bodily mechanisms are uncovered and understood as analytical platforms improve. It...
Tags: Pharm-Olam Insights
Ventilator-Associated Pneumonia (VAP) is a common complication of mechanical ventilation. Overall, the percentage of VAP or...
Tags: COVID-19
Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.
